← ANALYSTS · TIPRANKS
Amin Makarem · Jefferies
Hits
50%
1 of 2 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+43.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
2
Buy / hold / sell: 2 / 0 / 0
Upside of the analyst’s targets
+282.2%
Average over 2 current targets, to the last price
The market’s answer to the ratings
+6.9%
Day-0 move against SPY in the rating’s direction, average over 1 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Apr 9on TipRanks Apr 14 00:06 | URGNIWMUrogen Pharma · $1.8B | Initiated | Buy | $40.00 | +15.7% | +6.9%next day +5.1% · 5 days +1.0% | ↗ |
| Feb 16on TipRanks Feb 17 21:22 | FHTXIWMFoghorn Therapeutics · $112M | Reiterated | Buy | $12.00 | +548.6% | 0.0%next day +1.3% · 5 days +1.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗